Industry insiders recount top medtech wins of 2021

European Biotech Investors Cap Off Record Year in Fundraising

The End of Silicon Valley as We Know It?

Google’s New Company Will Discover Medicines Via Artificial Intelligence & Save Lives

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Tech analysts share new AI opportunities

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology